Loading...
Loading...
Among the 6 tracked institutional investors we monitor, SGMO (SANGAMO THERAPEUTICS INC) is held with a combined value of $7.64M across 22,519,918 shares. The largest holder is VANGUARD GROUP INC with a position worth $5.04M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund increased its holdings. 4 funds reduced their position.
Total Institutional Value
$7.64M
Total Shares Held
22,519,918
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $5.04M | 0.00% | New |
| 2 | BlackRock, Inc. | $1.12M | 0.00% | -0.5% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $947.27K | 0.00% | -54.5% |
| 4 | STATE STREET CORP | $418.44K | 0.00% | +25.0% |
| 5 | FMR LLC | $60.28K | 0.00% | -8.0% |
| 6 | CITADEL ADVISORS LLC | $48.42K | 0.00% | -56.2% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of SGMO with a position worth $5.04M, representing 0.00% of their portfolio. In total, 6 institutional investors hold SGMO with a combined value of $7.64M.
In the most recent quarter, 1 fund opened a new position in SGMO. Additionally, 1 increased their holdings and 4 reduced their positions.
Institutional investors hold $7.64M worth of SGMO stock across 6 positions. The largest institutional holder is VANGUARD GROUP INC with $5.04M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SGMO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SGMO positions.